Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Blueprint Medicines financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price



Market Capitalization

$3.3 B



$204 M

FY, 2022

CreditSafe Score

Score changed on Nov 29, 2023
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2019FY, 2020FY, 2021FY, 2022
Revenue growth, %49.4%1093.4%-77.3%
Cost of goods sold425.0K17.9M17.8M
Gross profit793.3M162.1M186.2M
Gross profit margin, %99.9%90.0%91.3%
General and administrative expense96.4M157.7M195.3M237.4M
Operating expense total427.8M484.6M804.1M714.8M
Interest income13.7M6.6M2.4M
Interest expense16.8M
Pre tax profit314.9M(641.1M)(552.3M)
Income tax expense1.1M3.0M5.2M
Net Income(347.7M)313.9M(644.1M)(557.5M)

Footer menu